WallStreetZenWallStreetZen

NASDAQ: TSBX
Turnstone Biologics Corp Earnings & Revenue

OverviewEarnings
DividendOwnership

TSBX past revenue growth

How has TSBX's revenue growth performed historically?
Company
-73.66%
Industry
144.63%
Market
17.55%
TSBX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TSBX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

TSBX earnings and revenue history

Current Revenue
$19.3M
Current Earnings
-$55.2M
Current Profit Margin
-286.1%

TSBX Return on Equity

Insufficient data to display

Be the first to know when TSBX announces earnings.

TSBX Return on Assets

Current Company
-53.7%
Current Industry
2.9%
TSBX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TSBX Return on Capital Employed

Current Company
-55.02%
Current Industry
19.5%

TSBX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TSBX$19.31M-$52.69M-$55.24M-56.34%N/A
MNOV$1.00M-$8.35M-$8.57M-50.23%N/A
RLYB$0.00-$74.41M-$74.56MN/AN/A
IKNA$9.16M-$65.59M-$68.17M-9.66%N/A
DTIL$48.73M-$50.83M-$61.32M+34.96%N/A
View Top Biotech Stocks

Turnstone Biologics Earnings & Revenue FAQ

What were TSBX's earnings last quarter?

On Invalid Date, Turnstone Biologics (NASDAQ: TSBX) reported Q4 2023 earnings per share (EPS) of $0.24, up 104.49% year over year. Total Turnstone Biologics earnings for the quarter were -$16.45 million. In the same quarter last year, Turnstone Biologics's earnings per share (EPS) was -$5.34.

If you're new to stock investing, here's how to buy Turnstone Biologics stock.

What was TSBX's earnings growth in the past year?

As of Q2 2024, Turnstone Biologics's earnings has grown year over year. Turnstone Biologics's earnings in the past year totalled -$55.24 million.

What was TSBX's revenue last quarter?

On Invalid Date, Turnstone Biologics (NASDAQ: TSBX) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Turnstone Biologics's revenue was $10.45 million.

What was TSBX's revenue growth in the past year?

As of Q2 2024, Turnstone Biologics's revenue has grown -73.66% year over year. This is 218.29 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Turnstone Biologics's revenue in the past year totalled $19.31 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.